npj Precision Oncology
An international, peer-reviewed journal committed to publishing cutting-edge scientific research in all aspects of precision oncology from basic science to translational applications to clinical medicine.
Computational mining the anticancer potential of non-oncology drugs
By building a machine learning model to combining knowledge of cancer genetics and network biology, we developed a personalized method to recommend FDA approved non-oncology drugs for cancer treatment.
Translational and Clinical Comparison of Whole Genome and Transcriptome to Panel Sequencing in Precision Oncology
Cancer treatment has entered a new era where molecular insights are crucial for treatment decisions. Our study examined whether the sequencing method significantly affects therapy recommendations and implementations for patients with rare or advanced tumors.
Uncovering distinct genomic and molecular signatures in triple-negative inflammatory breast cancer
This study is the most comprehensive genomic and transcriptomic analysis of triple-negative inflammatory breast cancer (TN-IBC) patient samples, uncovering unique genetic and immune characteristics. These findings aim to advance the diagnosis and treatment of this aggressive disease.
